Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Antonio Piga

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Physiology

Point Mutation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Roggero Simona; Quarello Paola; Vinciguerra Tiziana; Longo Filomena; Piga Antonio; Ramenghi Ugo
Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Origa Raffaella; Galanello Renzo; Perseu Lucia; Tavazzi Dario; Domenica Cappellini M; Terenzani Laura; Forni Gian Luca; Quarta Giovanni; Boetti Tatiana; Piga Antonio
Cholelithiasis in thalassemia major.
Piga Antonio; Longo Filomena; Duca Lorena; Roggero Simona; Vinciguerra Tiziana; Calabrese Roberto; Hershko Chaim; Cappellini Maria Domenica
High nontransferrin bound iron levels and heart disease in thalassemia major.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Antonio Piga (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Roggero Simona; Quarello Paola; Vinciguerra Tiziana; Longo Filomena; Piga Antonio; Ramenghi Ugo
Severe iron overload in Blackfan-Diamond anemia: a case-control study.
American journal of hematology 2009;84(11):729-32.
2009: Origa Raffaella; Galanello Renzo; Perseu Lucia; Tavazzi Dario; Domenica Cappellini M; Terenzani Laura; Forni Gian Luca; Quarta Giovanni; Boetti Tatiana; Piga Antonio
Cholelithiasis in thalassemia major.
European journal of haematology 2009;82(1):22-5.
2009: Piga Antonio; Longo Filomena; Duca Lorena; Roggero Simona; Vinciguerra Tiziana; Calabrese Roberto; Hershko Chaim; Cappellini Maria Domenica
High nontransferrin bound iron levels and heart disease in thalassemia major.
American journal of hematology 2009;84(1):29-33.
2008: Cappellini Maria D; Piga Antonio
Current status in iron chelation in hemoglobinopathies.
Current molecular medicine 2008;8(7):663-74.
2008: Angelucci Emanuele; Barosi Giovanni; Camaschella Clara; Cappellini Maria Domenica; Cazzola Mario; Galanello Renzo; Marchetti Monia; Piga Antonio; Tura Sante
Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders.
Haematologica 2008;93(5):741-52.
2008: Galanello Renzo; Piga Antonio; Cappellini Maria Domenica; Forni Gian Luca; Zappu Antonella; Origa Raffaella; Dutreix Catherine; Belleli Rossella; Ford John M; Rivière Gilles-Jacques; Balez Sébastien; Alberti Daniele; Séchaud Romain
Effect of food, type of food, and time of food intake on deferasirox bioavailability: recommendations for an optimal deferasirox administration regimen.
Journal of clinical pharmacology 2008;48(4):428-35.
2008: Porter John; Galanello Renzo; Saglio Giuseppe; Neufeld Ellis J; Vichinsky Elliott; Cappellini Maria Domenica; Olivieri Nancy; Piga Antonio; Cunningham Melody J; Soulières Denis; Gattermann Norbert; Tchernia Gilbert; Maertens Johan; Giardina Patricia; Kwiatkowski Janet; Quarta Giovanni; Jeng Michael; Forni Gian Luca; Stadler Michael; Cario Holger; Debusscher Louisette; Della Porta Matteo; Cazzola Mario; Greenberg Peter; Alimena Giuliana; Rabault Bertrand; Gathmann Insa; Ford John Malcolm; Alberti Daniele; Rose Christian
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
European journal of haematology 2008;80(2):168-76.
2006: Galanello Renzo; Piga Antonio; Forni Gian Luca; Bertrand Yves; Foschini Maria Loreta; Bordone Elena; Leoni Giovanbattista; Lavagetto Antonella; Zappu Antonietta; Longo Filomena; Maseruka Henry; Hewson Nicola; Sechaud Romain; Belleli Rossella; Alberti Daniele
Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.
Haematologica 2006;91(10):1343-51.
2006: Galbiati Silvia; Restagno Gabriella; Foglieni Barbara; Bonalumi Sara; Travi Maurizio; Piga Antonio; Sbaiz Luca; Chiari Marcella; Damin Francesco; Smid Maddalena; Valsecchi Luca; Pasi Federica; Ferrari Augusto; Ferrari Maurizio; Cremonesi Laura
Different approaches for noninvasive prenatal diagnosis of genetic diseases based on PNA-mediated enriched PCR.
Annals of the New York Academy of Sciences 2006;1075():137-43.
2006: Galanello Renzo; Kattamis Antonis; Piga Antonio; Fischer Roland; Leoni Giovanbattista; Ladis Vassilios; Voi Vincenzo; Lund Ulrich; Tricta Fernando
A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.
Haematologica 2006;91(9):1241-3.
2006: Piga Antonio
Survival improvement in thalassemia: who should take the credit?
Haematologica 2006;91(9):1154B.
2006: Piga Antonio; Galanello Renzo; Forni Gian Luca; Cappellini Maria Domenica; Origa Raffaella; Zappu Antonietta; Donato Guido; Bordone Elena; Lavagetto Antonella; Zanaboni Laura; Sechaud Romain; Hewson Nicola; Ford John M; Opitz Herbert; Alberti Daniele
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
Haematologica 2006;91(7):873-80.
2006: Borgna-Pignatti Caterina; Cappellini Maria Domenica; De Stefano Piero; Del Vecchio Giovanni Carlo; Forni Gian Luca; Gamberini Maria Rita; Ghilardi Roberta; Piga Antonio; Romeo Maria Antonietta; Zhao Huaqing; Cnaan Avital
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.
Blood 2006;107(9):3733-7.
2006: Pennell Dudley J; Berdoukas Vasili; Karagiorga Markissia; Ladis Vasili; Piga Antonio; Aessopos Athanassios; Gotsis Efstathios D; Tanner Mark A; Smith Gill C; Westwood Mark A; Wonke Beatrix; Galanello Renzo
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.
Blood 2006;107(9):3738-44.
2006: Cappellini Maria Domenica; Cohen Alan; Piga Antonio; Bejaoui Mohamed; Perrotta Silverio; Agaoglu Leyla; Aydinok Yesim; Kattamis Antonis; Kilinc Yurdanur; Porter John; Capra Marcello; Galanello Renzo; Fattoum Slaheddine; Drelichman Guillermo; Magnano Carmelo; Verissimo Monica; Athanassiou-Metaxa Miranda; Giardina Patricia; Kourakli-Symeonidis Alexandra; Janka-Schaub Gritta; Coates Thomas; Vermylen Christiane; Olivieri Nancy; Thuret Isabelle; Opitz Herbert; Ressayre-Djaffer Catherine; Marks Peter; Alberti Daniele
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.
Blood 2006;107(9):3455-62.
2006: Iolascon Achille; d'Apolito Maria; Servedio Veronica; Cimmino Flora; Piga Antonio; Camaschella Clara
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).
Blood 2006;107(1):349-54.
2005: Fischer Roland; Piga Antonio; Harmatz Paul; Nielsen Peter
Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry.
Annals of the New York Academy of Sciences 2005;1054():350-7.
2005: Piga A; Roggero S; Vinciguerra T; Sacchetti L; Gallo V; Longo F
Deferiprone: New insight.
Annals of the New York Academy of Sciences 2005;1054():169-74.
2005: Borgna-Pignatti C; Cappellini M D; De Stefano P; Del Vecchio G C; Forni G L; Gamberini M R; Ghilardi R; Origa R; Piga A; Romeo M A; Zhao H; Cnaan A
Survival and complications in thalassemia.
Annals of the New York Academy of Sciences 2005;1054():40-7.
2005: Piga A; Roggero S; Marletto F; Sacchetti L; Longo F
Combined use of oral chelators and desferrioxamine in thalassemia.
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():89-91.
2004: Ayi Kodjo; Turrini Franco; Piga Antonio; Arese Paolo
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Blood 2004;104(10):3364-71.
2004: Borgna-Pignatti Caterina; Rugolotto Simone; De Stefano Piero; Zhao Huaqing; Cappellini Maria Domenica; Del Vecchio Giovanni Carlo; Romeo Maria Antonietta; Forni Gian Luca; Gamberini Maria Rita; Ghilardi Roberta; Piga Antonio; Cnaan Avital
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
Haematologica 2004;89(10):1187-93.
2004: Cremonesi L; Galbiati S; Foglieni B; Smid M; Gambini D; Ferrari A; Viora E; Campogrande M; Pagliano M; Travi M; Piga A; Restagno G; Ferrari M
Feasibility study for a microchip-based approach for noninvasive prenatal diagnosis of genetic diseases.
Annals of the New York Academy of Sciences 2004;1022():105-12.
2004: Hershko Chaim; Cappellini Maria D; Galanello Renzo; Piga Antonio; Tognoni Gianni; Masera Giuseppe
Purging iron from the heart.
British journal of haematology 2004;125(5):545-51.
2004: Mariani R; Arosio C; Pelucchi S; Grisoli M; Piga A; Trombini P; Piperno A
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.
Gut 2004;53(5):756-8.
2004: Piperno Alberto; Roetto Antonella; Mariani Raffaella; Pelucchi Sara; Corengia Chiara; Daraio Filomena; Piga Antonio; Garozzo Giovanni; Camaschella Clara
Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload.
Haematologica 2004;89(3):359-60.
2004: Canavese Caterina; Bergamo Daniela; Ciccone Giovannino; Longo Filomena; Fop Fabrizio; Thea Alessandra; Martina Guido; Piga Antonio
Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.
Kidney international 2004;65(3):1091-8.
2004: Bugianesi Elisabetta; Manzini Paola; D'Antico Sergio; Vanni Ester; Longo Filomena; Leone Nicola; Massarenti Paola; Piga Antonio; Marchesini Giulio; Rizzetto Mario
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Hepatology (Baltimore, Md.) 2004;39(1):179-87.
2004: Borgna-Pignatti Caterina; Vergine Gianluca; Lombardo Turi; Cappellini Maria Domenica; Cianciulli Paolo; Maggio Aurelio; Renda Disma; Lai Maria Eliana; Mandas Antonella; Forni Gianluca; Piga Antonio; Bisconte Maria Grazia
Hepatocellular carcinoma in the thalassaemia syndromes.
British journal of haematology 2004;124(1):114-7.
2004: Di Stefano Marco; Chiabotto Patrizia; Roggia Cristiana; Garofalo Franco; Lala Roberto; Piga Antonio; Isaia Giovanni Carlo
Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs.
Journal of bone and mineral metabolism 2004;22(1):53-7.
2003: Cohen Alan R; Galanello Renzo; Piga Antonio; De Sanctis Vincenzo; Tricta Fernando
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone.
Blood 2003;102(5):1583-7.
2003: Galanello Renzo; Piga Antonio; Alberti Daniele; Rouan Marie-Claude; Bigler Hilde; Séchaud Romain
Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.
Journal of clinical pharmacology 2003;43(6):565-72.
2003: Fischer Roland; Longo Filomena; Nielsen Peter; Engelhardt Rainer; Hider Robert C; Piga Antonio
Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry.
British journal of haematology 2003;121(6):938-48.
2003: Piga Antoni; Gaglioti Carmen; Fogliacco Eugenia; Tricta Fernando
Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis.
Haematologica 2003;88(5):489-96.
2003: Ivaldi Giovanni; David Onorata; Baffico Maria; Leone Daniela; Baldi Maurizia; Parodi Maria Isola; Scimè-Degani Valeria; Piga Antonio; Scagni Paola; Rabino-Massa Emma; Ricco Giuseppe
Hb Trento: an elongated C-terminal beta chain due to a new frameshift mutation [beta144 (-A)].
Hemoglobin 2003;27(1):15-25.
2003: De Gobbi M; Caruso R; Daraio F; Chianale F; Pinto R M; Longo F; Piga A; Camaschella C
Diagnosis of juvenile hemochromatosis in an 11-year-old child combining genetic analysis and non-invasive liver iron quantitation.
European journal of pediatrics 2003;162(2):96-9.
2002: Wanless Ian R; Sweeney George; Dhillon Amar P; Guido Maria; Piga Antonio; Galanello Renzo; Gamberini M Rita; Schwartz Elias; Cohen Alan R
Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia.
Blood 2002;100(5):1566-9.
2002: Roetto Antonella; Merryweather-Clarke Alison T; Daraio Filomena; Livesey Karen; Pointon Jennifer J; Barbabietola Giuliana; Piga Antonio; Mackie Peter H; Robson Kathryn J H; Camaschella Clara
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4.
Blood 2002;100(2):733-4.
2002: Ceci Adriana; Baiardi Paola; Felisi Mariagrazia; Cappellini Maria Domenica; Carnelli Vittorio; De Sanctis Vincenzo; Galanello Renzo; Maggio Aurelio; Masera Giuseppe; Piga Antonio; Schettini Francesco; Stefàno Ippazio; Tricta Fernando
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients.
British journal of haematology 2002;118(1):330-6.
2001: Iolascon A; Giordano P; Storelli S; Li H H; Coppola B; Piga A; Fantola E; Forni G; Cianciulli P; Perrotta S; Magnano C; Maggio A; Mangiagli A; Devoto M
Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors.
Haematologica 2001;86(10):1112-3.
2001: Roetto A; Totaro A; Piperno A; Piga A; Longo F; Garozzo G; Calì A; De Gobbi M; Gasparini P; Camaschella C
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3.
Blood 2001;97(9):2555-60.
2000: Cohen A R; Galanello R; Piga A; Dipalma A; Vullo C; Tricta F
Safety profile of the oral iron chelator deferiprone: a multicentre study.
British journal of haematology 2000;108(2):305-12.
1999: Primignani P; Travi M; Biasi A; Sbrocca F; Piga A; Scagni P; Cantù Rajnoldi A
Identification of the new polymorphism IVS1-91 C-->T in the beta globin gene.
Human mutation 1999;14(3):272.
1999: Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
The influence of hemochromatosis mutations on iron overload of thalassemia major.
Haematologica 1999;84(9):799-803.
1999: de Franceschi L; Shalev O; Piga A; Collell M; Olivieri O; Corrocher R; Hebbel R P; Brugnara C
Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity.
The Journal of laboratory and clinical medicine 1999;133(1):64-9.
1998: Garofalo F; Piga A; Lala R; Chiabotto S; Di Stefano M; Isaia G C
Bone metabolism in thalassemia.
Annals of the New York Academy of Sciences 1998;850():475-8.
1998: Dresow B; Fischer R; Nielsen P; Gabbe E E; Piga A
Effect of oral iron chelator L1 on iron absorption in man.
Annals of the New York Academy of Sciences 1998;850():466-8.
1998: Reller K; Dresow B; Collell M; Fischer R; Engelhardt R; Nielsen P; Dürken M; Politis C; Piga A
Iron overload and antioxidant status in patients with beta-thalassemia major.
Annals of the New York Academy of Sciences 1998;850():463-5.
1998: Piga A; Longo F; Voi V; Facello S; Miniero R; Dresow B
Late effects of bone marrow transplantation for thalassemia.
Annals of the New York Academy of Sciences 1998;850():294-9.
1998: Borgna-Pignatti C; Rugolotto S; De Stefano P; Piga A; Di Gregorio F; Gamberini M R; Sabato V; Melevendi C; Cappellini M D; Verlato G
Survival and disease complications in thalassemia major.
Annals of the New York Academy of Sciences 1998;850():227-31.
1998: Cohen A; Galanello R; Piga A; Vullo C; Tricta F
A multi-center safety trial of the oral iron chelator deferiprone.
Annals of the New York Academy of Sciences 1998;850():223-6.
1998: Veglio F; Melchio R; Rabbia F; Molino P; Genova G C; Martini G; Schiavone D; Piga A; Chiandussi L
Blood pressure and heart rate in young thalassemia major patients.
American journal of hypertension 1998;11(5):539-47.
1998: Lala R; Chiabotto P; Di Stefano M; Isaia G C; Garofalo F; Piga A
Bone density and metabolism in thalassaemia.
Journal of pediatric endocrinology & metabolism : JPEM 1998;11 Suppl 3():785-90.
1997: Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Erer B; Gaziev D; Piga A; Di Gregorio F; Romeo M A; Mangiagli A; Petrelli E; Muretto P
Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.
Bone marrow transplantation 1997;20(9):767-72.
1997: Ivaldi G; Scimè-Degani V; David O; Baffico M; Baldi M; Leone D; Mazzocco M; Leone L; Piga A; Furian E; Ricco G
A new fast-moving variant causing erythrocytosis and mild hemolysis: Hb Gàmbara [beta 82(EF6)Lys-->Glu].
Hemoglobin 1997;21(4):345-61.
1996: Gabutti V; Piga A
Results of long-term iron-chelating therapy.
Acta haematologica 1996;95(1):26-36.
1995: Cavallo-Perin P; Pacini G; Cerutti F; Bessone A; Condo C; Sacchetti L; Piga A; Pagano G
Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia.
Metabolism: clinical and experimental 1995;44(3):281-6.
1993: Miniero R; Vassallo E; Busca A; Piga A; Perugini L; Madon E
Bone marrow transplantation for children with thalassemia: two years' experience with low-dose busulfan, citoxan and GM-CSF.
Bone marrow transplantation 1993;12 Suppl 1():51-3.
1993: Borgna-Pignatti C; Zurlo M G; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
Outcome of thalassemia treated with conventional therapy.
Bone marrow transplantation 1993;12 Suppl 1():2-4.
1991: Fortina P; Dianzani I; Serra A; Gottardi E; Saglio G; Farinasso L; Piga A; Gabutti V; Camaschella C
A newly-characterized alpha-thalassaemia-1 deletion removes the entire alpha-like globin gene cluster in an Italian family.
British journal of haematology 1991;78(4):529-34.
1990: Alfarano A; Gottardi E; Serra A; Piga A; Mandrino M; Mazza U; Camaschella C
Screening of beta-thalassemia mutations by PCR and ASO analysis in an Italian population of mixed geographic origin.
Haematologica 1990;75(6):506-9.
1989: Zurlo M G; De Stefano P; Borgna-Pignatti C; Di Palma A; Piga A; Melevendi C; Di Gregorio F; Burattini M G; Terzoli S
Survival and causes of death in thalassaemia major.
Lancet 1989;2(8653):27-30.
1989: Gabutti V; Piga A; Sacchetti L; Sandri A; Biginelli M; Saracco P; Ferri M
Quality of life and life expectancy in thalassemic patients with complications.
Progress in clinical and biological research 1989;309():35-41.
1989: Borgna-Pignatti C; Zurlo M G; DeStefano P; DiGregorio F; Di Palma A; Piga A; Melevendi C; Burattini M G; Terzoli S; Masera G
Survival in thalassemia with conventional treatment.
Progress in clinical and biological research 1989;309():27-33.
1989: David O; Vota M G; Piga A; Ramenghi U; Bosia A; Pescarmona G P
Pyrimidine 5'-nucleotidase acquired deficiency in beta-thalassemia: involvement of enzyme-SH groups in the inactivation process.
Acta haematologica 1989;82(2):69-74.
1988: Piga A; Luzzatto L; Capalbo P; Gambotto S; Tricta F; Gabutti V
High-dose desferrioxamine as a cause of growth failure in thalassemic patients.
European journal of haematology 1988;40(4):380-1.
1988: Albera R; Pia F; Morra B; Lacilla M; Bianco L; Gabutti V; Piga A
Hearing loss and desferrioxamine in homozygous beta-thalassemia.
Audiology : official organ of the International Society of Audiology 1988;27(4):207-14.
1987: Ciriotti G; Gabutti V; Marostica G; Piga A; Barattia G; Accornero M
[Echocardiographic evaluation of the cardiac function in Cooley's disease]
Minerva cardioangiologica 1987;35(6):351-4.
1986: Piga A; Davico S; Magliano M; Luzzatto L; Sandri A; Gabutti V
[Evaluation of iron overload in thalassemia]
La Pediatria medica e chirurgica : Medical and surgical pediatrics 1986;8(1):9-13.
1986: Massaglia P; Pozzan M T; Piga A; Davico S; Luzzatto L; Carpignano M
[Psychological aspects of thalassemia]
La Pediatria medica e chirurgica : Medical and surgical pediatrics 1986;8(1):27-31.
1984: Jean G; Terzoli S; Mauri R; Borghetti L; Di Palma A; Piga A; Magliano M; Melevendi M; Cattaneo M
Cirrhosis associated with multiple transfusions in thalassaemia.
Archives of disease in childhood 1984;59(1):67-70.
1984: Cooper E H; Forbes M A; Bowen M; Gabutti V; Piga A
Plasma beta-2-microglobulin and fibronectin levels in beta-thalassaemia.
Acta haematologica 1984;71(4):257-62.
1983: Miniero R; Piga A; Luzzatto L; Gabutti V
Vitamin E and beta-thalassaemia.
Haematologica 1983;68(4):562-3.
1982: Fargion S; Taddei M T; Gabutti V; Piga A; Di Palma A; Capra L; Fontanelli G; Avanzini A
Early iron overload in beta-thalassaemia major: when to start chelation therapy?
Archives of disease in childhood 1982;57(12):929-33.
1982: Gabutti V; Piga A; Nicola P; Vullo C; Capra L; Di Palma A; Masera G; Terzoli S; Mauri R
Haemoglobin levels and blood requirement in thalassaemia.
Archives of disease in childhood 1982;57(2):156-8.
1980: Gabutti V; Miniero R; Piga A; Incarbone E; Sacchetti L; Balegno G
Behaviour of myeloid precursors in homozygous beta thalassaemia.
British journal of haematology 1980;45(4):599-605.
1980: Gabutti V; Piga A; Fortina P; Miniero R; Nicola P
Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemia.
Acta haematologica 1980;64(2):103-8.
1977: Baratono S; Cerutti F; Pagliero R; Piga A; Riva C; Sacchetti C; Altare F
[Infantile diabetes mellitus, current problems of prevention, early diagnosis and treatment]
Minerva pediatrica 1977;29(40):2409-24.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Antonio Piga

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Geographic Areas

Anatomy

Living Beings

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Antonio Piga (preview)

All Publications